Clinical Trials
21
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Acellular Dermal Matrix Investigation in Breast Reconstruction
- Conditions
- Breast Reconstruction
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- RTI Surgical
- Target Recruit Count
- 467
- Registration Number
- NCT06456554
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸NYU Langone Health, New York, New York, United States
A Prospective Study of Fortiva in Hernia Repair
- Conditions
- Ventral HerniaAbdominal Wall ReconstructionIncisional Hernia
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- RTI Surgical
- Target Recruit Count
- 120
- Registration Number
- NCT06101979
- Locations
- 🇬🇧
James Paget University Hospital, Great Yarmouth, United Kingdom
Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up
- Conditions
- Spinal Stenosis Occipito-Atlanto-AxialSpinal Stenosis CervicalSpinal Stenosis Cervicothoracic RegionSpinal DiseaseSpinal Instability
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2020-10-27
- Lead Sponsor
- RTI Surgical
- Target Recruit Count
- 60
- Registration Number
- NCT04171544
- Locations
- 🇺🇸
Las Vegas Neurosurgical Institute, Las Vegas, Nevada, United States
🇺🇸Spine Nevada, Reno, Nevada, United States
A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis
- Conditions
- Mammoplasty
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- RTI Surgical
- Target Recruit Count
- 87
- Registration Number
- NCT03744013
- Locations
- 🇩🇪
Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany
🇩🇪Frankfurt University Hospital, Frankfurt am Main, Germany
🇩🇪University Hospital Technical University, Munich, München, Germany
Evaluation of the Fortilink IBF System With TETRAfuse Technology
- Conditions
- Cervical and Lumbar Fusion
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- RTI Surgical
- Target Recruit Count
- 119
- Registration Number
- NCT03699891
- Locations
- 🇺🇸
Los Angeles Orthopedic Institute, Sherman Oaks, California, United States
🇺🇸Rocky Mountain Spine, Lone Tree, Colorado, United States
🇺🇸Florida Back Institute, Boca Raton, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
RTI Surgical Initiates ADMIRE Study for Cortiva Allograft Dermis in Breast Reconstruction
RTI Surgical has enrolled the first patient in the ADMIRE study to evaluate Cortiva Allograft Dermis for implant-based breast reconstruction.